In our previous report, CLDN4 overexpression increased malignancy by promoting resistance to anticancer drugs [3]; however, our results show that CLDN4 overexpression increases cancer malignant phenotypes in situations without usage of anticancer drugs. The gene discussed is CLDN4; the disease is cancer.